Ann: NUH Initiates Strategic Review Supported by $1.85M Cap Raise, page-118

From the announcement: "a prioritisation on the completion of the new chip development with Realtek and the next generation of HP Hearing PRO". Incomplete development of the chip could explain the delay in FDA submission and production of the Gen 4 bud. At least there is indication of an an intention to progress Gen 4. If they have produced enough inventory for supply of the one per POS per month and have sold less than one thousand, then at this rate of sales there should be enough for some more months on Walmart etc. Are they in the process of an A/M now in order to provide funds, or is that just an idea at this stage? Another Australian company in the same game is Audeara, a small company but with progressive and adaptive management and who are establishing links overseas. Whoever Nuheara approaches, a merger and continuation as a revitalized spec would yield more favourable results for shareholders than an acquisition.